{"SPADE_N_13978": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13978", "Peptide Name": "FK13-a2 (synthetic AMPs, LL-37 derived, Arg-rich; XXA, UCLL1c)", "Source": "Amino acid substitution, human cathelicidin analog, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "FWRIVRWIKRWLR", "Sequence Length": 13, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-inflammatory", "Hemolytic"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1915.34, "PI": 12.0, "Hydrophobicity": -0.37, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Rajasekaran G, Kim EY, Shin SY. 2017", "Reference": "Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.PubMed", "Title": "LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity"}], "Frequent Amino Acids": "RWI", "Absent Amino Acids": "ACDEGHMNOPQSTUY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 6, "Positive Residues": 5, "Negative Residues": 0, "Net Charge": 5, "Comments": "Peptide design: obtained by replacing R23 of FK13-a1 with W.Sequence analysis: APD analysis reveals that this sequence is most similar (92.31%) toFK13-a1.  R: 31%; W: 23%; I: 15%. GRAVY: -0.37; M Wt: 1915.366; M formula:  C95H146N29O14, mol ex coeff: 16650.Activity: Active against E. coli KCTC 1682 (MIC 8 uM), P. aeruginosa KCTC 1637 (MIC 4 uM), S. typhimurium KCTC 1926 (MIC 4 uM), Gram+ B. subtilis KCTC 3068 (MIC 4 uM), S. epidermidis KCTC 1917 (MIC 8 uM), and  S. aureus KCTC1621 (MIC 2 uM). Non-standard assay: activity was measured in 1% peptone where LL-37 (control) is active against S. aureus.Toxicity: human RBC: HC50 14.0 uM, highly hemolytic.Structure: helical in 50% TFE.Anti-inflammatory: suppressed NO 99.5%, and TNF-alpha 68.2% (cf. LL-37: 100% and 90.4%, respectively).", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_14810", "Similarity": 1.0, "Sequence": "VRWI"}, {"SPADE_ID": "SPADE_N_12365", "Similarity": 1.0, "Sequence": "WRRWIRWL"}, {"SPADE_ID": "SPADE_N_12367", "Similarity": 1.0, "Sequence": "RWIRWL"}]}}}